Beijing Institute of Biotechnology, Beijing, China.
Cell Death Differ. 2010 Aug;17(8):1277-87. doi: 10.1038/cdd.2010.8. Epub 2010 Feb 12.
Galectin-3 (Gal3) has important roles in tumor transformation and metastasis. This study shows that c-Abl and Abl-related gene (Arg) associate with and phosphorylate Gal3. The SH (Src homology)3 domains of c-Abl/Arg bind to a P(80)GPPSGP motif of Gal3, and Tyr79 and Tyr118 are the major tyrosine phosphorylation sites. A consequence of this interaction and phosphorylation is the significant impairment of chaperone-mediated autophagy of Gal3. Cells expressing Gal3 and treated with the c-Abl/Arg inhibitor STI571, Gal3-depleted cells, and Gal3-depleted cells expressing Gal3 phosphorylation mutants all display an increased sensitivity to apoptosis-inducing agents. In addition, tumor cells expressing the phosphorylation mutants show impaired tumorigenicity. These results partially explain the antiapoptotic effect of Abl and Arg. As tumors frequently overexpress Gal3, a c-Abl/Arg-specific inhibitor may potentially be applied along with other antitumor drugs to target the lysosomal degradation of Gal3 in tumor therapy.
半乳糖凝集素-3(Gal3)在肿瘤转化和转移中具有重要作用。本研究表明,c-Abl 和 Abl 相关基因(Arg)与 Gal3 结合并使其磷酸化。c-Abl/Arg 的 SH3 结构域与 Gal3 的 P(80)GPPSGP 基序结合,Tyr79 和 Tyr118 是主要的酪氨酸磷酸化位点。这种相互作用和磷酸化的结果是 Gal3 的伴侣介导的自噬受到显著抑制。表达 Gal3 并接受 c-Abl/Arg 抑制剂 STI571 处理、Gal3 耗尽的细胞以及表达 Gal3 磷酸化突变体的 Gal3 耗尽的细胞均对凋亡诱导剂表现出更高的敏感性。此外,表达磷酸化突变体的肿瘤细胞表现出肿瘤形成能力受损。这些结果部分解释了 Abl 和 Arg 的抗凋亡作用。由于肿瘤经常过度表达 Gal3,因此 c-Abl/Arg 特异性抑制剂可能与其他抗肿瘤药物一起应用于肿瘤治疗,以靶向 Gal3 的溶酶体降解。